(Q60685577)

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Non-Hodgkin's lymphomas.V. Results of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Non-Hodgkin's lymphomas. II. Single agent chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Single Agent Sequential Chemotherapy in Non-Hodgkin's Lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

The value of staging laparotomy in non-Hodgkin's lymphomas.(With emphasis on the histiocytic type)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Nitrogen-mustard therapy for Hodgkin's disease, lymphosarcoma, the leukemias, and other disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Shnider BI, Salvin LG, Schneiderman MA, Colsky J, Owens AH Jr,+OWENS AH JR, Krant MJ, Miller SP, Frei E 3d,+FREI E III, Hall TC, Spurr CL, McIntyre OR,+MACINTYRE OR, Hoogstraten B, Holland JF: The use of mechlorethamine, cyclophosphamide, and uracil

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Efficacy of cyclophosphamide in the management of reticulum cell sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Vincristine therapy of lymphomas and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

VINBLASTINE SULPHATE IN THE TREATMENT OF MALIGNANT DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Use of a Methyl Hydrazine Derivative (Natulan®), Especially in Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Clinical trials with N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Phase II evaluation of adriamycin in human neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

A clinical review of bleomycin--a new antineoplastic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Adriamycin. A new anticancer drug with significant clinical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

1,3-Bis(2-Chloroethyl)-1-Nitrosourea (Bcnu) And Other Nitrosoureas In Cancer Treatment: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Mechlorethamine HCl and cyclophosphamide in the treatment of Hodgkin's disease and the lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Cyclophosphamide therapy. Its use in leukemia, lymphoma and solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Neoplastic disease. Treatment with vinblastine. A cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Non-Hodgkin's lymphoma: Recent observations on natural history and intensive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and Prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Cyclic chemotherapy in lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021

Combination sequential chemotherapy in advanced reticulum cell sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2874%2980001-0

7 January 2021